HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evangelos Terpos Selected Research

Monoclonal Gammopathy of Undetermined Significance

11/2022Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
1/2022miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
1/2018Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia.
6/2014The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
9/2012Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.
3/2011Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
12/2009Serum levels of total-RANKL in multiple myeloma.
3/2009Angiogenesis in Waldenström's macroglobulinemia.
6/2007Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
10/2006Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evangelos Terpos Research Topics

Disease

175Multiple Myeloma
12/2022 - 01/2003
60Neoplasms (Cancer)
11/2022 - 10/2004
50Bone Diseases (Bone Disease)
07/2021 - 09/2003
30Bone Resorption
08/2021 - 01/2003
27COVID-19
02/2022 - 01/2020
24Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2022 - 06/2007
15Immunoglobulin Light-chain Amyloidosis
12/2021 - 10/2007
15Osteoporosis
07/2021 - 11/2003
15Neoplasm Metastasis (Metastasis)
12/2020 - 01/2007
11Monoclonal Gammopathy of Undetermined Significance
11/2022 - 09/2004
11Paraproteinemias (Monoclonal Gammopathy)
11/2022 - 12/2008
11Infections
02/2022 - 05/2008
11Pain (Aches)
01/2021 - 01/2004
10Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 06/2008
10Anemia
01/2018 - 05/2008
9Disease Progression
01/2022 - 09/2003
9beta-Thalassemia (Cooley's Anemia)
12/2019 - 06/2006
9Thalassemia
12/2019 - 07/2005
8Residual Neoplasm
12/2021 - 01/2013
8Osteonecrosis (Kienbock's Disease)
05/2019 - 07/2006
7Iron Overload
01/2022 - 07/2005
7Thrombosis (Thrombus)
07/2021 - 09/2013
7Spontaneous Fractures (Pathological Fracture)
01/2021 - 01/2003
7Thrombocytopenia (Thrombopenia)
01/2021 - 01/2002
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2015 - 01/2002
6Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2007
6Inflammation (Inflammations)
01/2022 - 02/2011
6Breast Neoplasms (Breast Cancer)
12/2021 - 07/2008
6Lymphoma (Lymphomas)
09/2021 - 05/2007
6B-Cell Lymphoma (Lymphoma, B Cell)
09/2021 - 02/2009
6Spinal Cord Compression
01/2021 - 01/2004
6Neutropenia
01/2021 - 08/2007
6Hypercalcemia (Milk Alkali Syndrome)
01/2020 - 01/2004
6Peripheral Nervous System Diseases (PNS Diseases)
10/2019 - 12/2009
6Renal Insufficiency (Renal Failure)
05/2016 - 05/2008
5Chromosome Aberrations (Chromosome Abnormalities)
01/2021 - 07/2012
5Plasmacytoma
01/2020 - 11/2005
5Hemolysis
07/2019 - 01/2002
5Non-alcoholic Fatty Liver Disease
12/2018 - 01/2013
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2011 - 01/2002
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2022 - 02/2009
4Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 10/2004

Drug/Important Bio-Agent (IBA)

51Bortezomib (Velcade)FDA Link
12/2021 - 10/2004
38Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 02/2006
35Diphosphonates (Bisphosphonates)IBA
06/2021 - 01/2003
34Lenalidomide (CC 5013)FDA Link
01/2022 - 07/2010
30Zoledronic Acid (Zometa)FDA Link
06/2021 - 07/2006
27Biomarkers (Surrogate Marker)IBA
06/2022 - 09/2003
23Proteasome InhibitorsIBA
06/2022 - 10/2004
22OsteoprotegerinIBA
01/2019 - 08/2003
20DenosumabFDA Link
08/2021 - 04/2009
18Monoclonal AntibodiesIBA
09/2021 - 08/2007
18Collagen Type I (Type I Collagen)IBA
01/2014 - 01/2003
17RANK LigandIBA
11/2018 - 08/2003
17Alkaline PhosphataseIBA
05/2017 - 01/2003
15OsteocalcinIBA
12/2019 - 01/2003
14carfilzomibIBA
06/2022 - 02/2017
14Neutralizing AntibodiesIBA
06/2022 - 01/2021
14Tartrate-Resistant Acid PhosphataseIBA
12/2019 - 01/2003
13Immunoglobulin M (IgM)IBA
11/2022 - 06/2007
13AntibodiesIBA
02/2022 - 06/2016
13Proteins (Proteins, Gene)FDA Link
10/2021 - 09/2004
12CytokinesIBA
01/2022 - 06/2007
12Pamidronate (Aredia)FDA LinkGeneric
06/2019 - 01/2003
11VaccinesIBA
06/2022 - 01/2021
11BNT162 VaccineIBA
02/2022 - 01/2021
10daratumumabIBA
06/2022 - 01/2018
10L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 03/2009
9Immunomodulating AgentsIBA
09/2021 - 01/2013
9IronIBA
01/2019 - 07/2005
8Immunoglobulins (Immunoglobulin)IBA
02/2022 - 12/2008
8Rituximab (Mabthera)FDA Link
09/2021 - 08/2007
8Melphalan (Alkeran)FDA LinkGeneric
10/2019 - 01/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 07/2006
7pomalidomideIBA
01/2022 - 01/2013
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021 - 08/2007
7Proteasome Endopeptidase Complex (Proteasome)IBA
12/2019 - 08/2007
7collagen type I trimeric cross-linked peptideIBA
01/2014 - 09/2004
7OsteopontinIBA
11/2011 - 01/2006
6DNA (Deoxyribonucleic Acid)IBA
11/2022 - 01/2002
6Messenger RNA (mRNA)IBA
06/2022 - 02/2014
6LigandsIBA
06/2021 - 11/2003
6Chemokine CCL3IBA
01/2018 - 10/2003
6Angiopoietin-2IBA
10/2017 - 06/2007
6Angiopoietin-1IBA
10/2017 - 06/2007
6Interleukin-6 (Interleukin 6)IBA
11/2011 - 01/2003
6Protein Isoforms (Isoforms)IBA
11/2011 - 09/2003
5Pharmaceutical PreparationsIBA
01/2019 - 01/2013
5ParaproteinsIBA
01/2019 - 01/2003
5ACE-011IBA
01/2018 - 05/2011
5CreatinineIBA
01/2016 - 05/2008
5Chelating AgentsIBA
03/2014 - 07/2005
5Thalidomide (Thalomid)FDA Link
08/2013 - 02/2006
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2011 - 10/2008
4Cell-Free Nucleic AcidsIBA
11/2022 - 12/2018

Therapy/Procedure

103Therapeutics
12/2022 - 01/2002
15Drug Therapy (Chemotherapy)
08/2021 - 01/2003
13Radiotherapy
09/2021 - 01/2003
11Stem Cell Transplantation
01/2021 - 11/2005
6Aftercare (After-Treatment)
01/2022 - 07/2006